U170221C3 |
Monoclonal antibody (MAb) |
Amino acids, Peptides, Proteins |
Humanized monoclonal IgG1 |
BioPro IEX SF |
SF00S03-1046WP |
U250805C |
Utilisation of AEX-MS for charge variant analysis of
IgG4-based mAbs! |
Amino acids, Peptides, Proteins |
In-house IgG4-based mAbs
NISTmAb |
BioPro IEX QF |
QF00S05-1046WP |
U250805C |
Utilisation of AEX-MS for charge variant analysis of
IgG4-based mAbs! |
Amino acids, Peptides, Proteins |
In-house IgG4-based mAbs
NISTmAb |
BioPro IEX SF |
SF00S05-1046WP |
U170210 |
Monoclonal antibody (MAb) |
Amino acids, Peptides, Proteins |
Humanized monoclonal IgG1 |
YMC-Pack Diol |
DL30S02-1546PTH |
M180604AA |
Monoclonal antibody (MAb) |
Amino acids, Peptides, Proteins |
Humanized monoclonal IgG1 |
YMC-SEC MAB |
DLM25S03-3046WT |
W200519A |
Online native HIC-MS analysis of a monoclonal antibody mixture |
Amino acids, Peptides, Proteins |
Monoclonal antibodies |
BioPro HIC BF |
BHB00S04-1046WT |
U240403A |
Antibody drugs |
Amino acids, Peptides, Proteins |
Bevacizumab
Trastuzumab |
Accura BioPro IEX SF |
SF00S03-05Q1PTC |
U240403B |
Antibody drugs |
Amino acids, Peptides, Proteins |
Bevacizumab
Trastuzumab |
Accura BioPro IEX SF |
SF00S03-05Q1PTC |
W191118F |
Antibody drugs |
Amino acids, Peptides, Proteins |
Adalimumab
Trastuzumab
Bevacizumab |
BioPro HIC HT |
BHH00SQ3-1046PTH |
U190423A |
Antibody drugs |
Amino acids, Peptides, Proteins |
Bevacizumab
Rituximab
NIST mAb
Trastuzumab
Adalimumab |
BioPro HIC BF |
BHB00S04-1046WT |
U190426A |
Antibody drugs |
Amino acids, Peptides, Proteins |
Bevacizumab
Rituximab
NIST mAb
Trastuzumab
Adalimumab |
BioPro HIC BF |
BHB00S04-1046WT |
U190422B |
Antibody drugs |
Amino acids, Peptides, Proteins |
Adalimumab
Brentuximab
Pembrolizumab
Reslizumab |
BioPro HIC BF |
BHB00S04-1046WT |
W200519B |
Online native HIC-MS analysis of monoclonal antibody molecular variants |
Amino acids, Peptides, Proteins |
Monoclonal antibody molecular variant |
BioPro HIC BF |
BHB00S04-1046WT |
W200519C |
Online native HIC-MS analysis of cys-linked ADCs |
Amino acids, Peptides, Proteins |
Cysteine-conjugated ADC mimic deglycosylated by PNGase F |
BioPro HIC BF |
BHB00S04-1046WT |
W200121J |
Drug-to-Antibody Ratio (DAR) analysis of ADC's |
Amino acids, Peptides, Proteins |
Brentuximab vedotin |
BioPro HIC HT |
BHH00SQ3-1046PTH |
L171130C |
Drug-to-Antibody Ratio (DAR) analysis of ADCs |
Amino acids, Peptides, Proteins |
Cysteine-conjugated ADC mimic |
BioPro HIC BF |
BHB00S04-1046WT |
M180803EA |
Antibody-Drug Conjugate (ADC) |
Amino acids, Peptides, Proteins |
Cysteine-conjugated ADC mimic |
YMC-SEC MAB |
DLM25S03-3046WT |
AB201114A |
Antibody-Drug Conjugate (Brentuximab vedotin) |
Amino acids, Peptides, Proteins |
Antibody Drug Conjugate (ADC) |
YMC-SEC MAB |
DLM25S03-3046WT |
AK240328C |
Antibody-Drug Conjugate (Brentuximab vedotin) |
Amino acids, Peptides, Proteins |
Antibody Drug Conjugate (ADC) |
Accura BioPro IEX SF |
SF00S03-10Q1PTC |
C240226B |
Antibody-Drug Conjugate (Brentuximab vedotin) |
Amino acids, Peptides, Proteins |
Antibody Drug Conjugate (ADC) |
Accura BioPro IEX SF |
SF00S03-1046PTC |